...
首页> 外文期刊>International journal of dermatology >Disseminated strongyloidiasis in immunocompromised patients--report of three cases.
【24h】

Disseminated strongyloidiasis in immunocompromised patients--report of three cases.

机译:免疫功能低下患者的弥散性圆线虫病-报告三例。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Strongyloides stercoralis is an intestinal nematode of humans. The characteristic cutaneous manifestation of strongyloidiasis is larva currens. Patients with suppressed immunity can develop a severe disseminated strongyloidiasis involving wide spread of the larvae to extraintestinal organs, outside the usual migration pattern. Patients with cell-mediated immunodeficiency and on corticosteroid therapy appear to be at highest risk for the development of this highly fatal entity. METHODS: We present three patients with disseminated strongyloidiasis. All patients were immunocompromised and were undergoing corticosteroid therapy. Physical examination revealed a rapidly progressive purpuric petechial eruption with a reticulated pattern, mainly over the abdomen. RESULTS: The histopathologic findings of the skin biopsies revealed a purpuric lymphomonocytic vasculitis that compromised the superficial dermis. In one skin biopsy, a larva was identified. None of our patients had eosinophilia. Strongyloides stercoralis was isolated in the fluid of the three patients, either before or after they died. CONCLUSION: The risk of disseminated strongyloidiasis in patients with impaired cell-mediated immunity is unknown; however, given the poor prognosis of disseminated strongyloidiasis, consideration should be given to the screening of patients at increased risk of infection.
机译:背景:甾体类固醇是人类的肠道线虫。圆线虫病的特征性皮肤表现是幼虫。免疫力低下的患者会发展出严重的弥散性圆线虫病,涉及幼虫广泛传播到肠外器官,这超出了通常的迁移方式。具有细胞介导的免疫缺陷并且接受皮质类固醇治疗的患者似乎最有可能发展这种高度致命的实体。方法:我们介绍了3例弥漫性圆线虫病患者。所有患者均免疫功能低下,正在接受激素治疗。体格检查发现紫癜性皮疹迅速进展,呈网状分布,主要分布在腹部。结果:皮肤活检的组织病理学发现显示,紫癜性淋巴单核血管炎损害了浅表真皮。在一次皮肤活检中,发现了一个幼虫。我们的患者均无嗜酸性粒细胞增多。在三名患者死亡之前或之后的液体中均分离到了类固醇类固醇。结论:细胞介导的免疫力受损的患者存在弥散性类圆线虫病的风险尚不清楚。然而,鉴于弥散性类圆线虫病的预后较差,应考虑筛查感染风险增加的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号